236 related articles for article (PubMed ID: 10441119)
1. Structure of the extended-spectrum class C beta-lactamase of Enterobacter cloacae GC1, a natural mutant with a tandem tripeptide insertion.
Crichlow GV; Kuzin AP; Nukaga M; Mayama K; Sawai T; Knox JR
Biochemistry; 1999 Aug; 38(32):10256-61. PubMed ID: 10441119
[TBL] [Abstract][Full Text] [Related]
2. The D-methyl group in beta-lactamase evolution: evidence from the Y221G and GC1 mutants of the class C beta-lactamase of Enterobacter cloacae P99.
Adediran SA; Zhang Z; Nukaga M; Palzkill T; Pratt RF
Biochemistry; 2005 May; 44(20):7543-52. PubMed ID: 15895997
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of turnover of cefotaxime by the Enterobacter cloacae P99 and GCl beta-lactamases: two free enzyme forms of the P99 beta-lactamase detected by a combination of pre- and post-steady state kinetics.
Kumar S; Adediran SA; Nukaga M; Pratt RF
Biochemistry; 2004 Mar; 43(9):2664-72. PubMed ID: 14992604
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C beta-lactamase.
Kim JY; Jung HI; An YJ; Lee JH; Kim SJ; Jeong SH; Lee KJ; Suh PG; Lee HS; Lee SH; Cha SS
Mol Microbiol; 2006 May; 60(4):907-16. PubMed ID: 16677302
[TBL] [Abstract][Full Text] [Related]
5. Structure of the SHV-1 beta-lactamase.
Kuzin AP; Nukaga M; Nukaga Y; Hujer AM; Bonomo RA; Knox JR
Biochemistry; 1999 May; 38(18):5720-7. PubMed ID: 10231522
[TBL] [Abstract][Full Text] [Related]
6. Role of the omega-loop in the activity, substrate specificity, and structure of class A beta-lactamase.
Banerjee S; Pieper U; Kapadia G; Pannell LK; Herzberg O
Biochemistry; 1998 Mar; 37(10):3286-96. PubMed ID: 9521648
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of class A and class C beta-lactamases by penems: crystallographic structures of a novel 1,4-thiazepine intermediate.
Nukaga M; Abe T; Venkatesan AM; Mansour TS; Bonomo RA; Knox JR
Biochemistry; 2003 Nov; 42(45):13152-9. PubMed ID: 14609325
[TBL] [Abstract][Full Text] [Related]
8. Effect of an amino acid insertion into the omega loop region of a class C beta-lactamase on its substrate specificity.
Nukaga M; Taniguchi K; Washio Y; Sawai T
Biochemistry; 1998 Jul; 37(29):10461-8. PubMed ID: 9671516
[TBL] [Abstract][Full Text] [Related]
9. Crystallographic structure of a phosphonate derivative of the Enterobacter cloacae P99 cephalosporinase: mechanistic interpretation of a beta-lactamase transition-state analog.
Lobkovsky E; Billings EM; Moews PC; Rahil J; Pratt RF; Knox JR
Biochemistry; 1994 Jun; 33(22):6762-72. PubMed ID: 8204611
[TBL] [Abstract][Full Text] [Related]
10. Molecular modeling of Henry-Michaelis and acyl-enzyme complexes between imipenem and Enterobacter cloacae P99 beta-lactamase.
Fenollar-Ferrer C; Donoso J; Frau J; Muñoz F
Chem Biodivers; 2005 May; 2(5):645-56. PubMed ID: 17192008
[TBL] [Abstract][Full Text] [Related]
11. Chromophoric spin-labeled beta-lactam antibiotics for ENDOR structural characterization of reaction intermediates of class A and class C beta-lactamases.
Mustafi D; Hofer JE; Huang W; Palzkill T; Makinen MW
Spectrochim Acta A Mol Biomol Spectrosc; 2004 May; 60(6):1279-89. PubMed ID: 15134725
[TBL] [Abstract][Full Text] [Related]
12. Role of beta-lactam carboxyl group on binding of penicillins and cephalosporins to class C beta-lactamases.
Fenollar-Ferrer C; Frau J; Donoso J; Muñoz F
Proteins; 2003 May; 51(3):442-52. PubMed ID: 12696055
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the E166A mutant of extended-spectrum beta-lactamase Toho-1 at 1.8 A resolution.
Ibuka A; Taguchi A; Ishiguro M; Fushinobu S; Ishii Y; Kamitori S; Okuyama K; Yamaguchi K; Konno M; Matsuzawa H
J Mol Biol; 1999 Feb; 285(5):2079-87. PubMed ID: 9925786
[TBL] [Abstract][Full Text] [Related]
14. An engineered disulfide bond between residues 69 and 238 in extended-spectrum beta-lactamase Toho-1 reduces its activity toward third-generation cephalosporins.
Shimizu-Ibuka A; Matsuzawa H; Sakai H
Biochemistry; 2004 Dec; 43(50):15737-45. PubMed ID: 15595829
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the mechanism of resistance to third-generation cephalosporins by class C beta-lactamases by using chemical complementation.
Carter BT; Lin H; Goldberg SD; Althoff EA; Raushel J; Cornish VW
Chembiochem; 2005 Nov; 6(11):2055-67. PubMed ID: 16250067
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the recombinant Enterobacter cloacae P99 AmpC beta-lactamase and its mutants based on a phi105 prophage system in Bacillus subtilis.
Tsang MW; Leung YC
Protein Expr Purif; 2007 Sep; 55(1):75-83. PubMed ID: 17638579
[TBL] [Abstract][Full Text] [Related]
17. Molecular evolution of a class C beta-lactamase extending its substrate specificity.
Nukaga M; Haruta S; Tanimoto K; Kogure K; Taniguchi K; Tamaki M; Sawai T
J Biol Chem; 1995 Mar; 270(11):5729-35. PubMed ID: 7890700
[TBL] [Abstract][Full Text] [Related]
18. On the importance of a methyl group in beta-lactamase evolution: free energy profiles and molecular modeling.
Bernstein NJ; Pratt RF
Biochemistry; 1999 Aug; 38(32):10499-510. PubMed ID: 10441146
[TBL] [Abstract][Full Text] [Related]
19. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of class C beta-lactamases: structure of a reaction intermediate with a cephem sulfone.
Crichlow GV; Nukaga M; Doppalapudi VR; Buynak JD; Knox JR
Biochemistry; 2001 May; 40(21):6233-9. PubMed ID: 11371184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
